137 related articles for article (PubMed ID: 22401960)
1. Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.
Agarwal S; Uchida Y; Mittapalli RK; Sane R; Terasaki T; Elmquist WF
Drug Metab Dispos; 2012 Jun; 40(6):1164-9. PubMed ID: 22401960
[TBL] [Abstract][Full Text] [Related]
2. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
Biali ME; Auvity S; Cisternino S; Smirnova M; Hacker M; Zeitlinger M; Mairinger S; Tournier N; Bauer M; Langer O
Mol Pharm; 2023 Nov; 20(11):5877-5887. PubMed ID: 37883694
[TBL] [Abstract][Full Text] [Related]
3. Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier.
Sun A; Wang J
Pharm Res; 2023 Nov; 40(11):2667-2675. PubMed ID: 37704894
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor.
Bauer F; Kuntner C; Bankstahl JP; Wanek T; Bankstahl M; Stanek J; Mairinger S; Dörner B; Löscher W; Müller M; Erker T; Langer O
Bioorg Med Chem; 2010 Aug; 18(15):5489-97. PubMed ID: 20621487
[TBL] [Abstract][Full Text] [Related]
5. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
[TBL] [Abstract][Full Text] [Related]
6. Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 at the Blood-Brain Barrier.
Cannon RE; Richards AC; Trexler AW; Juberg CT; Sinha B; Knudsen GA; Birnbaum LS
Environ Health Perspect; 2020 Mar; 128(3):37002. PubMed ID: 32212926
[TBL] [Abstract][Full Text] [Related]
7. Maternal and Fetal Exposure to (-)-Δ
Chen X; Unadkat JD; Mao Q
Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
[TBL] [Abstract][Full Text] [Related]
8. Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood-brain barrier.
Lye P; Bloise E; Matthews SG
Fluids Barriers CNS; 2023 Jan; 20(1):8. PubMed ID: 36721242
[TBL] [Abstract][Full Text] [Related]
9. P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine.
Liao MZ; Gao C; Shireman LM; Phillips B; Risler LJ; Neradugomma NK; Choudhari P; Prasad B; Shen DD; Mao Q
Pharmacol Res; 2017 May; 119():61-71. PubMed ID: 28111265
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain.
Porteous CM; Menon DK; Aigbirhio FI; Smith RA; Murphy MP
Biochim Biophys Acta; 2013 Jun; 1830(6):3458-65. PubMed ID: 23454352
[TBL] [Abstract][Full Text] [Related]
11. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
12. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
[TBL] [Abstract][Full Text] [Related]
13. Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
Zhang W; Oh JH; Zhang W; Rathi S; Larson JD; Wechsler-Reya RJ; Sirianni RW; Elmquist WF
J Pharmacol Exp Ther; 2023 Dec; 387(3):315-327. PubMed ID: 37827699
[TBL] [Abstract][Full Text] [Related]
14. ATP-binding cassette (ABC) drug transporters in the developing blood-brain barrier: role in fetal brain protection.
Eng ME; Imperio GE; Bloise E; Matthews SG
Cell Mol Life Sci; 2022 Jul; 79(8):415. PubMed ID: 35821142
[TBL] [Abstract][Full Text] [Related]
15. Brain region-specific regulation of histone acetylation and efflux transporters in mice.
You D; Shin HM; Mosaad F; Richardson JR; Aleksunes LM
J Biochem Mol Toxicol; 2019 Jun; 33(6):e22318. PubMed ID: 30897286
[TBL] [Abstract][Full Text] [Related]
16. A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier.
Kim DG; Bynoe MS
J Clin Invest; 2016 May; 126(5):1717-33. PubMed ID: 27043281
[TBL] [Abstract][Full Text] [Related]
17. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
[TBL] [Abstract][Full Text] [Related]
18. Tetrabromobisphenol A (TBBPA) Alters ABC Transport at the Blood-Brain Barrier.
Cannon RE; Trexler AW; Knudsen GA; Evans RA; Birnbaum LS
Toxicol Sci; 2019 Jun; 169(2):475-484. PubMed ID: 30830211
[TBL] [Abstract][Full Text] [Related]
19. Development of an
Watanabe R; Esaki T; Ohashi R; Kuroda M; Kawashima H; Komura H; Natsume-Kitatani Y; Mizuguchi K
J Med Chem; 2021 Mar; 64(5):2725-2738. PubMed ID: 33619967
[TBL] [Abstract][Full Text] [Related]
20. 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.
Durk MR; Chan GN; Campos CR; Peart JC; Chow EC; Lee E; Cannon RE; Bendayan R; Miller DS; Pang KS
J Neurochem; 2012 Dec; 123(6):944-53. PubMed ID: 23035695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]